© shutterstock
Naobios and Sumagen sign exclusive partnership to develop HIV vaccine
©Naobios
Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate combined with immune checkpoint inhibitors
© Pamela Chemla
Axoltis Pharma receives authorization to launch SEALS – phase II clinical trial for ALS patients with drug candidate NX210c
©Axoltis
AACR 2024: PDC*line Pharma presents interim clinical results from last cohort of patients in phase I/II trial with PDC*lung01 cancer vaccine
© PDC*Line
Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure
© iStock
Metafora Biosystems secures reimbursement in France for first IVD to help diagnose Glut1 deficiency syndrome
Carthera: positive results from phase I/II clinical trial of SonoCloud-9 in treatment of glioblastoma published in Nature Communications
© Shuttershock / Jaray Shanshed
StromaCare appoints Georges Rawadi as CEO
© Marie-Eve Brouet
Walloon Government launches innovation partnership with €81 million budget over three years, dedicated to ATMPs, in collaboration with BioWin and the Public service of Wallonia
©BioWin